Successful treatment with gefitinib after Stevens–Johnson syndrome associated with afatinib therapy in a patient with adenocarcinoma of the lung

We report a case of a 65-year-old woman with stage IV lung adenocarcinoma who experienced Stevens–Johnson syndrome (SJS) during afatinib therapy. The patient received afatinib as the first-line therapy after the confirmation of harboring an exon 19 deletion mutation in the epidermal growth factor re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int Cancer Conf J
Autores principales: Otsuka, Tomoyuki, Tanaka, Aya, Azukizawa, Hiroaki, Sasaki, Shoko, Ishijima, Mikako, Matsuki, Takanori, Osa, Akio, Nakatani, Takeshi, Kuroyama, Muneyoshi, Hirata, Haruhiko, Kijima, Takashi
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Japan 2016
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6498331/
https://ncbi.nlm.nih.gov/pubmed/31149467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-016-0269-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares